Campbell & Co Investment Adviser’s ResMed RMD Stock Holding History

Campbell & Co Investment Adviser’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45M	Buy	12,586 +7,709	+158%	+$1.6M	0.13%	258
2026 Q1	$1.09M	Sell	4,877 -11,175	-70%	-$2.78M	0.06%	484
2025 Q4	$3.87M	Buy	16,052 +6,722	+72%	+$1.72M	0.19%	147
2025 Q3	$2.55M	Buy	9,330 +8,084	+649%	+$2.21M	0.19%	123
2025 Q2	$321K	Sell	1,246 -1,943	-61%	-$463K	0.02%	935
2025 Q1	$714K	Buy	+3,189	New	+$744K	0.05%	546
2023 Q3	–	Sell	-1,239	Closed	-$271K	–	1154
2023 Q2	$271K	Sell	1,239 -148	-11%	-$33K	0.05%	703
2023 Q1	$304K	Sell	1,387 -1,447	-51%	-$314K	0.06%	598
2022 Q4	$590K	Buy	+2,834	New	+$623K	0.14%	241
2022 Q1	–	Sell	-3,423	Closed	-$892K	–	868
2021 Q4	$892K	Buy	+3,423	New	+$888K	0.31%	74
2019 Q1	–	Sell	-2,696	Closed	-$340K	–	596
2018 Q4	$340K	Buy	+2,696	New	+$289K	0.34%	114

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Campbell & Co Investment Adviser's RMD Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its ResMed (RMD) stake by 158% in Q2 2026, buying an estimated $1.6M and bringing the position to 12,586 shares worth $2.45M. The position accounts for 0.13% of the portfolio, ranked #258.

Campbell & Co Investment Adviser first reported a position in RMD in Q4 2018 and has held it in 11 quarters since. The position peaked at $3.87M in Q4 2025. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Campbell & Co Investment Adviser held 12,586 shares of ResMed worth $2.45M as of Q2 2026.
Campbell & Co Investment Adviser bought 7,709 ResMed shares in Q2 2026, an estimated $1.6M.
ResMed made up 0.13% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #258 holding.
Campbell & Co Investment Adviser first reported a position in ResMed in Q4 2018 and has held it in 11 quarters since.
Campbell & Co Investment Adviser's ResMed position peaked at $3.87M in Q4 2025.
448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.